⟵ Go Back

NeuroShield® available and fully reimbursed in South Africa

October 2020

We are pleased to announce that Monarch Bioimplants and Merlin Med (Pty) Ltd have entered a distribution agreement for South Africa.

Merlin Med has already obtained registration and full reimbursement for NeuroShield in South Africa.
“Merlin Med has done a great work to quickly register and obtain a reimbursement code for NeuroShield. We are all amazed and excited with the opportunity to enter the South African market.” said Dr. Rivelino Montenegro, CEO of Monarch Bioimplants.

According to Carel Potgieter, CEO of Merlin Med “bringing innovative medical products to South Africa is what we love to do. NeuroShield’s advantages are clearly understood by surgeons and patients and now with a reimbursement code, NeuroShield will become a well-known brand among surgeons.” Medical centers of excellence in South Africa started to become aware of the new available product and the first lots have been shipped to South Africa.